U.S. flag

An official website of the United States government

NM_000369.5(TSHR):c.326G>A (p.Arg109Gln) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Aug 18, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003555948.2

Allele description [Variation Report for NM_000369.5(TSHR):c.326G>A (p.Arg109Gln)]

NM_000369.5(TSHR):c.326G>A (p.Arg109Gln)

Gene:
TSHR:thyroid stimulating hormone receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q31.1
Genomic location:
Preferred name:
NM_000369.5(TSHR):c.326G>A (p.Arg109Gln)
HGVS:
  • NC_000014.9:g.81087962G>A
  • NG_009206.1:g.137438G>A
  • NM_000369.5:c.326G>AMANE SELECT
  • NM_001018036.3:c.326G>A
  • NM_001142626.3:c.326G>A
  • NP_000360.2:p.Arg109Gln
  • NP_001018046.1:p.Arg109Gln
  • NP_001136098.1:p.Arg109Gln
  • LRG_523:g.137438G>A
  • NC_000014.8:g.81554306G>A
Protein change:
R109Q; ARG109GLN
Links:
OMIM: 603372.0009; dbSNP: rs121908865
NCBI 1000 Genomes Browser:
rs121908865
Molecular consequence:
  • NM_000369.5:c.326G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001018036.3:c.326G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001142626.3:c.326G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004297138Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Aug 18, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Next-generation sequencing analysis of TSHR in 384 Chinese subclinical congenital hypothyroidism (CH) and CH patients.

Fu C, Wang J, Luo S, Yang Q, Li Q, Zheng H, Hu X, Su J, Zhang S, Chen R, Luo J, Zhang Y, Shen Y, Wei H, Meng D, Gui B, Zeng Z, Fan X, Chen S.

Clin Chim Acta. 2016 Nov 1;462:127-132. doi: 10.1016/j.cca.2016.09.007. Epub 2016 Sep 13.

PubMed [citation]
PMID:
27637299

A frequent oligogenic involvement in congenital hypothyroidism.

de Filippis T, Gelmini G, Paraboschi E, Vigone MC, Di Frenna M, Marelli F, Bonomi M, Cassio A, Larizza D, Moro M, Radetti G, Salerno M, Ardissino D, Weber G, Gentilini D, Guizzardi F, Duga S, Persani L.

Hum Mol Genet. 2017 Jul 1;26(13):2507-2514. doi: 10.1093/hmg/ddx145.

PubMed [citation]
PMID:
28444304
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004297138.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

ClinVar contains an entry for this variant (Variation ID: 6438). This missense change has been observed in individual(s) with autosomal recessive hypothyroidism (PMID: 9100579, 27637299, 28444304, 30083029). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs121908865, gnomAD 0.007%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 109 of the TSHR protein (p.Arg109Gln). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TSHR protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Experimental studies have shown that this missense change affects TSHR function (PMID: 9100579, 30083029).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024